United States - English - NLM (National Library of Medicine)

a-s medication solutions - prednisolone sodium phosphate (unii: iv021nxa9j) (prednisolone - unii:9phq9y1olm) - prednisolone sodium phosphate oral solution is indicated in the following conditions: systemic fungal infections. hypersensitivity to the drug or any of its components.

Australia - English - Department of Health (Therapeutic Goods Administration)

blackmores ltd - dibasic potassium phosphate,dibasic sodium phosphate -

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - fludarabine phosphate, quantity: 50 mg - injection, concentrated - excipient ingredients: dibasic sodium phosphate dihydrate; sodium hydroxide; water for injections; nitrogen - fludarabine ebewe is indicated for the treatment of b-cell chronic lymphocytic leukaemia.

Australia - English - Department of Health (Therapeutic Goods Administration)

pfizer australia pty ltd - dibasic sodium phosphate dodecahydrate, quantity: 192 mg/ml; monobasic potassium phosphate, quantity: 17.4 mg/ml - injection, concentrated - excipient ingredients: water for injections - indications as at 30 april 2004: treatment of severe hypophosphataemia (serum levels less than 0.3 mmol/l) and other degrees of hypophosphataemia when oral therapy is not possible. the cause of hypophosphataemia should be identified and treated.

United States - English - NLM (National Library of Medicine)

citra labs, llc - sodium pyruvate (unii: pod38aif08) (pyruvic acid - unii:8558g7rutr), inosine (unii: 5a614l51ct) (inosine - unii:5a614l51ct), adenine (unii: jac85a2161) (adenine - unii:jac85a2161), sodium phosphate, dibasic (unii: gr686lba74) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37), sodium phosphate, monobasic, monohydrate (unii: 593yog76rn) (phosphate ion - unii:nk08v8k8hr, sodium cation - unii:lyr4m0nh37) - sodium pyruvate 0.55 g in 50 ml - rejuvesol ® solution is intended only for the extracorporeal rejuvenation of a rbc. it should never be directly administered to humans. rejuvesol ® solution must not be added to whole blood because the additional plasma may reduce the effectiveness of the rejuvenation process. immediately after rejuvenation, rbc must either be washed via an approved protocol prior to transfusion or glycerolized and frozen. rbc which have been rejuvenated, glycerolized, and frozen must be deglycerolized via an approved protocol prior to transfusion. rbc rejuvenated before 6 days of storage may achieve 2,3-dpg levels in excess of 2 times normal and atp levels in excess of 1.5 times normal. 5,6 in patients with reduced arterial blood p0 2 of less than 40 torr, the use of rbc rejuvenated before 6 days of storage are contraindicated because their high 2,3-dpg levels and low oxygen affinity may impair proper oxygenation of the red blood cells in the lung. 7 rej

United States - English - NLM (National Library of Medicine)

baxter healthcare corporation - sodium chloride (unii: 451w47iq8x) (sodium cation - unii:lyr4m0nh37, chloride ion - unii:q32zn48698), potassium chloride (unii: 660yq98i10) (potassium cation - unii:295o53k152, chloride ion - unii:q32zn48698), magnesium sulfate heptahydrate (unii: sk47b8698t) (magnesium cation - unii:t6v3lhy838), sodium phosphate, dibasic, heptahydrate (unii: 70wt22sf4b) (sodium cation - unii:lyr4m0nh37, phosphate ion - unii:nk08v8k8hr), potassium phosphate, monobasic (unii: 4j9fj0hl51) (phosphate ion - unii:nk08v8k8hr - sodium chloride 800 mg in 100 ml - isotonic solution for irrigation only. not for injection.

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - pravastatin sodium, quantity: 20 mg - tablet - excipient ingredients: microcrystalline cellulose; sodium lauryl sulfate; colloidal anhydrous silica; dibasic sodium phosphate; croscarmellose sodium; povidone; lactose monohydrate; iron oxide red; magnesium stearate - as an adjunct to diet for the treatment of hypercholesterolaemia. prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. patients with previous myocardial infarction including those who have normal (4.0 to 5.5 mmol/l) serum cholesterol levels. patients with unstable angina pectoris (see clinical trials). as an adjunct to diet and lifestyle modification for the treatment of heterozygous familial hypercholesterolaemia in children and adolescent patients aged 8 years and older (see clinical trials).

Australia - English - Department of Health (Therapeutic Goods Administration)

sandoz pty ltd - pravastatin sodium, quantity: 80 mg - tablet - excipient ingredients: microcrystalline cellulose; colloidal anhydrous silica; povidone; sodium lauryl sulfate; dibasic sodium phosphate; croscarmellose sodium; magnesium stearate; iron oxide red; lactose monohydrate - as an adjunct to diet for the treatment of hypercholesterolaemia. prior to initiating therapy with pravastatin, secondary causes of hypercholesterolaemia (e.g. poorly controlled diabetes mellitus, hypothyroidism, nephrotic syndrome, dysproteinaemias, obstructive liver disease, other drug therapy, alcoholism) should be identified and treated. patients with previous myocardial infarction including those who have normal (4.0 to 5.5 mmol/l) serum cholesterol levels. patients with unstable angina pectoris (see clinical trials). as an adjunct to diet and lifestyle modification for the treatment of heterozygous familial hypercholesterolaemia in children and adolescent patients aged 8 years and older (see clinical trials).

Canada - English - Health Canada

chester labs, inc. - sodium phosphate monobasic; sodium phosphate dibasic - enema - 16g; 6g - sodium phosphate monobasic 16g; sodium phosphate dibasic 6g - cathartics and laxatives

Canada - English - Health Canada

pharmascience inc - sodium phosphate monobasic; sodium phosphate dibasic - solution - 480mg; 180mg - sodium phosphate monobasic 480mg; sodium phosphate dibasic 180mg - cathartics and laxatives